Search

Benjamin A Auspitz

age ~50

from Cambridge, MA

Also known as:
  • Benjamin Adam Auspitz
  • Ben A Auspitz
Phone and address:
41 Prince St #2, Cambridge, MA 02139
617-661-2612

Benjamin Auspitz Phones & Addresses

  • 41 Prince St #2, Cambridge, MA 02139 • 617-661-2612
  • West Somerville, MA
  • Los Angeles, CA

Us Patents

  • Methods And Reagents For The Treatment Of Immunoinflammatory Disorders

    view source
  • US Patent:
    8080553, Dec 20, 2011
  • Filed:
    Sep 7, 2006
  • Appl. No.:
    11/517593
  • Inventors:
    Curtis Keith - Boston MA, US
    Alexis Borisy - Arlington MA, US
    Grant R. Zimmermann - Somerville MA, US
    Palaniyandi Manivasakam - West Roxbury MA, US
    Nicole Hurst - Boston MA, US
    Michael A. Foley - Chestnut Hill MA, US
    Michael S. Slavonic - Quincy MA, US
    Brendan Smith - Somerville MA, US
    Benjamin A. Auspitz - Cambridge MA, US
  • Assignee:
    Zalicus Inc. - Cambridge MA
  • International Classification:
    A01N 43/54
    A01N 43/90
    A61K 31/517
    A61K 31/519
    C07D 239/42
    C07D 401/04
  • US Classification:
    5142581, 514256
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
  • Combinations For The Treatment Of Fungal Infections

    view source
  • US Patent:
    20040157837, Aug 12, 2004
  • Filed:
    Nov 7, 2003
  • Appl. No.:
    10/703807
  • Inventors:
    George Serbedzija - Sudbury MA, US
    Lisa Johansen - Belmont MA, US
    Todd Chappell - Boston MA, US
    Curtis Keith - Boston MA, US
    Grant Zimmermann - Somerville MA, US
    M. Nichols - Boston MA, US
    Benjamin Auspitz - Cambridge MA, US
  • International Classification:
    A61K031/541
    A61K031/5377
    A61K031/496
    A61K031/325
  • US Classification:
    514/227800, 514/231800, 514/252110, 514/316000, 514/478000
  • Abstract:
    The invention features methods and compositions for treating a patient diagnosed with, or at risk for developing, a fungal infection.
  • Methods And Reagents For The Treatment Of Diseases And Disorders Associated With Increased Levels Of Proinflammatory Cytokines

    view source
  • US Patent:
    20040220153, Nov 4, 2004
  • Filed:
    Sep 24, 2003
  • Appl. No.:
    10/670488
  • Inventors:
    Palaniyandi Manivasakam - W. Roxbury MA, US
    Brendan Smith - Boston MA, US
    Jason Fong - Philadelphia PA, US
    Benjamin Auspitz - Cambridge MA, US
    M. Nichols - Boston MA, US
    Curtis Keith - Boston MA, US
    Grant Zimmermann - Somerville MA, US
    Bradley Brasher - Natick MA, US
    Noah Sachs - Boston MA, US
    Todd Chappell - Boston MA, US
  • International Classification:
    A61K031/60
    A61K031/59
    A61K031/573
    A61K031/405
  • US Classification:
    514/171000, 514/419000, 514/167000, 514/159000, 514/559000, 514/725000
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering an SSRI or analog or metabolite thereof and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing an SSRI or analog or metabolite thereof and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.
  • Combination Therapy For The Treatment Of Immunoinflammatory Disorders

    view source
  • US Patent:
    20040224876, Nov 11, 2004
  • Filed:
    Feb 12, 2004
  • Appl. No.:
    10/777518
  • Inventors:
    Bradley Brasher - Natick MA, US
    Todd Chappell - Boston MA, US
    Palaniyandi Manivasakam - West Roxbury MA, US
    Noah Sachs - Boston MA, US
    Brendan Smith - Boston MA, US
    Benjamin Auspitz - Cambridge MA, US
  • International Classification:
    A61K038/13
  • US Classification:
    514/011000
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a non-steroidal immunophilin-dependent immunosuppressant (NsIDI) and an NsIDI enhancer (NsIDIE) or analog or metabolite thereof to the patient. The invention also features a pharmaceutical composition containing an NsIDI and NsIDIE or analog or metabolite thereof for the treatment or prevention of an immunoinflammatory disorder.
  • Methods And Reagents For The Treatment Of Diseases And Disorders Associated With Increased Levels Of Proinflammatory Cytokines

    view source
  • US Patent:
    20040229849, Nov 18, 2004
  • Filed:
    Feb 12, 2004
  • Appl. No.:
    10/777517
  • Inventors:
    Palaniyandi Manivasakam - West Roxbury MA, US
    Brendan Smith - Boston MA, US
    Jason Fong - Philadelphia PA, US
    Benjamin Auspitz - Cambridge MA, US
    M. Nichols - Boston MA, US
    Curtis Keith - Boston MA, US
    Grant Zimmermann - Somerville MA, US
    Bradley Brasher - Natick MA, US
    Noah Sachs - Boston MA, US
    Todd Chappell - Boston MA, US
  • International Classification:
    A61K031/60
    A61K031/59
    A61K031/5513
    A61K031/559
    A61K031/203
  • US Classification:
    514/159000, 514/171000, 514/220000, 514/167000, 514/406000, 514/454000, 514/725000, 514/649000, 514/469000
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering an SSRI or analog or metabolite thereof and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing an SSRI or analog or metabolite thereof and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.
  • Methods And Reagents For The Treatment Of Immunoinflammatory Disorders

    view source
  • US Patent:
    20050119160, Jun 2, 2005
  • Filed:
    Oct 15, 2004
  • Appl. No.:
    10/966228
  • Inventors:
    Curtis Keith - Boston MA, US
    Alexis Borisy - Arlington MA, US
    Grant Zimmermann - Somerville MA, US
    Palaniyandi Manivasakam - Brighton MA, US
    Nicole Hurst - Boston MA, US
    Michael Foley - Chestnut Hill MA, US
    Michael Slavonic - Quincy MA, US
    Brendan Smith - Boston MA, US
    Benjamin Auspitz - Cambridge MA, US
  • International Classification:
    A61K038/00
    A61K031/60
    A61K031/59
    A61K031/551
    A61K031/525
    A61K031/519
    A61K031/5415
    A61K031/415
  • US Classification:
    514002000, 514220000, 514225800, 514262100, 514649000, 514406000, 514471000, 514251000, 514165000, 514570000, 514167000, 514559000
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering to the patient a tetra-substituted pyrimidopyrimidine, either alone or in combination with one or more additional agents. The invention also features a composition containing a tetra-substituted pyrimidopyrimidine in combination with one or more additional agents.
  • Methods And Reagents For The Treatment Of Diseases And Disorders Associated With Increased Levels Of Proinflammatory Cytokines

    view source
  • US Patent:
    20050153947, Jul 14, 2005
  • Filed:
    Sep 20, 2004
  • Appl. No.:
    10/947455
  • Inventors:
    Mahesh Padval - Waltham MA, US
    Palaniyandi Manivasakam - West Roxbury MA, US
    Brendan Smith - Boston MA, US
    Jason Fong - Philadelphia PA, US
    Benjamin Auspitz - Cambridge MA, US
    M. Nichols - Boston MA, US
    Curtis Keith - Boston MA, US
    Grant Zimmerman - Somervillle MA, US
    Bradley Brasher - Natick MA, US
    Noah Sachs - Boston MA, US
    Todd Chappell - Boston MA, US
  • International Classification:
    A61K031/573
    A61K031/137
  • US Classification:
    514171000, 514649000, 424472000
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering an SSRI or analog or metabolite thereof and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing an SSRI or analog or metabolite thereof and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.
  • Methods And Reagents For The Treatment Of Inflammatory Disorders

    view source
  • US Patent:
    20050187200, Aug 25, 2005
  • Filed:
    Nov 12, 2004
  • Appl. No.:
    10/987554
  • Inventors:
    Benjamin Auspitz - Cambridge MA, US
    Alexis Borisy - Arlington MA, US
    Jason Fong - Philadelphia PA, US
    Nicole Hurst - Boston MA, US
    Curtis Keith - Boston MA, US
    Palaniyandi Manivasakam - West Roxbury MA, US
    Robyn Sackeyfio - Ann Arbor MI, US
    Michael Slavonic - Quincy MA, US
    Brendan Smith - Boston MA, US
    Grant Zimmermann - Somerville MA, US
  • International Classification:
    A61K031/60
    A61K031/59
    A61K031/551
    A61K031/573
    A61K031/5415
  • US Classification:
    514159000, 514171000, 514221000, 514167000, 514225800
  • Abstract:
    The invention features a method for treating a patient diagnosed with, or at risk of developing, an immunoinflammatory disorder by administering a tricyclic compound and, optionally, a corticosteroid or other compound to the patient. The invention also features a pharmaceutical composition containing a tricyclic compound and a corticosteroid or other compound for the treatment or prevention of an immunoinflammatory disorder.

Get Report for Benjamin A Auspitz from Cambridge, MA, age ~50
Control profile